Showing results (321-330 of 982) with videos related to

Sort By:
Pageof 99
Acta Neurologica Scandinavica|August 3, 2004
TRIPSTAR: prioritizing oral triptan treatment attributes in migraine managementP J Goadsby, D W Dodick, M D Ferrari, et al.
La Medicina Del Lavoro|March 1, 1992
[The determination of serum amino-terminal procollagen type-III propeptide (PIIINP) in occupational exposure to rock wool fiber]A Cavalleri, F Gobba, D Ferrari, et al.
Cephalalgia : an International Journal of Headache|August 1, 1997
The factor V Leiden mutation (R506Q) is not a major risk factor for migrainous cerebral infarctionJ Haan, L J Kappelle, H de Ronde, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 22, 1999
Bovine isolated middle cerebral artery contractions to antimigraine drugsK I Roon, A Maassen Van Den Brink, M D Ferrari, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 12, 1998
[Channelopathies: a genetic explanation of migraine and other paroxysmal neurologic disorders]G M Terwindt, R A Ophoff, J Haan, et al.
Cephalalgia : an International Journal of Headache|October 1, 1992
Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study GroupW H Visser, M D Ferrari, E M Bayliss, et al.
Neurology|August 1, 1992
Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacksJ F Caekebeke, M D Ferrari, C P Zwetsloot, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 14, 2011
Neuro-oncological diagnosis in patients without histological confirmationP Gaviani, A Silvani, E Lamperti, et al.
Cephalalgia : an International Journal of Headache|May 1, 1996
Familial hemiplegic migraine: a clinical comparison of families linked and unlinked to chromosome 19.DMG RGG M Terwindt, R A Ophoff, J Haan, et al.
Neurology|February 1, 1996
311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding studyW H Visser, K B Klein, R C Cox, et al.
Pageof 99